Furthermore, a decreased expression of endoglin and ALK1 on activated monocytes and blood outgrowth endothelial cells (BOECs) from HHT patients has been described (Sanz-Rodriguez et al., 2004; Fernandez-L et al., 2007a), as discussed below. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.